The Dual Reuptake Wars
The Carlat Psychiatry Report, Volume 3, Number 1, January 2005
https://www.thecarlatreport.com/newsletter-issue/tcprv3n1/
From The Carlat Psychiatry Report, January 2005, Antidepressant Roundup 2005
Issue Links: | Editorial Information
Daniel Carlat, MD
Dr. Carlat has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.
I know what you’re thinking, “This is going to be a Cymbalta vs. Effexor article, and Cymbalta will get another TCR drubbing as it did last year.” Not quite. In fact, there are two major battles to be reviewed: Effexor vs. Cymbalta, but probably more relevant, Effexor vs. Lexapro.
You can't view details of this content, please login or buy subscription here